High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation.
暂无分享,去创建一个
Harriet Noreen | Marcelo Fernandez-Vina | John Klein | Michelle Setterholm | Machteld Oudshoorn | Mary Horowitz | J. Klein | M. Horowitz | Stephanie J. Lee | S. Spellman | C. Hurley | M. Setterholm | E. Petersdorf | N. Flomenberg | D. Weisdorf | C. Anasetti | H. Noreen | L. Baxter‐Lowe | T. Williams | M. Oudshoorn | M. Eapen | Mary Eapen | Stephanie J Lee | D. Confer | M. Haagenson | Dennis L Confer | Carolyn K Hurley | Michael Haagenson | Stephen Spellman | Neal Flomenberg | Lee Ann Baxter-Lowe | Claudio Anasetti | Daniel Weisdorf | Effie Petersdorf | Thomas M Williams | M. Fernández-Viña | J. Klein
[1] G. Longton,et al. The Role of HLA-DPB 1 Disparity in the Development of Acute Graft-Versus-Host Disease Following Unrelated Donor Marrow Transplantation , 2003 .
[2] K. Sullivan,et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. , 1980, The American journal of medicine.
[3] N. Kröger,et al. Isolated HLA-C mismatches in unrelated donor transplantation for CML , 2004, Bone Marrow Transplantation.
[4] C Anasetti,et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. , 2001, Blood.
[5] Harriet Noreen,et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. , 2004, Blood.
[6] G. Longton,et al. The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation. , 1995, Blood.
[7] J Crowley,et al. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. , 1999, Statistics in medicine.
[8] References , 1971 .
[9] N. Russell,et al. HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants. , 2006, Blood.
[10] H. Inoko,et al. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. , 2002, Blood.
[11] Effie W Petersdorf,et al. Limits of HLA mismatching in unrelated hematopoietic cell transplantation. , 2004, Blood.
[12] Anajane G. Smith,et al. The biological significance of HLA‐DP gene variation in haematopoietic cell transplantation , 2001, British journal of haematology.
[13] Anajane G. Smith,et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. , 1998, Blood.
[14] A. Nademanee,et al. Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience. , 2001, Blood.
[15] Shunichi Kato,et al. High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism. , 2007, Blood.
[16] H. Greinix,et al. Impact of HLA class I high-resolution mismatches on chronic graft-versus-host disease and survival of patients given hematopoietic stem cell grafts from unrelated donors , 2005, Bone Marrow Transplantation.
[17] Takato O. Yoshida,et al. EFFECT OF MATCHING OF CLASS I HLA ALLELES ON CLINICAL OUTCOME AFTER TRANSPLANTATION OF HEMATOPOIETIC STEM CELLS FROM AN UNRELATED DONOR , 1998 .
[18] A. Begovich,et al. A high degree of HLA disparity arises from limited allelic diversity: analysis of 1775 unrelated bone marrow transplant donor-recipient pairs. , 2007, Human immunology.
[19] P. Neiman,et al. CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S , 1974, Transplantation.
[20] R. Soiffer,et al. HLA-C mismatch is associated with inferior survival after unrelated donor non-myeloablative hematopoietic stem cell transplantation , 2006, Bone Marrow Transplantation.
[21] Effie W Petersdorf,et al. MHC Haplotype Matching for Unrelated Hematopoietic Cell Transplantation , 2007, PLoS medicine.
[22] Larry R. Smith,et al. Cross-Reactive Neuraminidase Antibodies Afford Partial Protection against H5N1 in Mice and Are Present in Unexposed Humans , 2007, PLoS medicine.